NON-SMALL CELL LUNG CANCER STAGE IIIB
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IIIB explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IIIB trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer drug alectinib put to the test in Dose-Finding trial
Disease control Recruiting nowThis study is testing the drug alectinib in 45 Mexican patients with advanced ALK-positive non-small cell lung cancer. In the first phase, patients receive increasing doses every 21 days to measure drug levels and safety. In the second phase, the chosen dose is given to see how w…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IIIB
Phase: PHASE1, PHASE2 • Sponsor: Instituto Nacional de Cancerologia de Mexico • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug shrinks lung tumors before surgery in early trial
Disease control Recruiting nowThis study is testing whether the drug trastuzumab deruxtecan can shrink tumors in people with a specific type of lung cancer (HER2-amplified or HER2-mutated) before they have surgery. About 14 participants with stage II to IIIB non-small cell lung cancer will receive the drug an…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IIIB
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC